Table 4. Final logistic regression model demonstrating association between number of lifetime sexual partners, age at first sexual intercourse, smoking, OC use and HPV-16, -18, and -31 seropositivity, also adjusted for age and recent sexual partners (excluding study virgins).
HPV-16 seropositive |
HPV-18 seropositive |
HPV-31 seropositive |
||||
---|---|---|---|---|---|---|
# (%) | OR (95% CI) | # (%) | OR (95% CI) | # (%) | OR (95% CI) | |
Age | ||||||
<25 | 166 (15.7) | — | 134 (12.7) | — | 179 (16.9) | — |
25–29 | 182 (14.2) | 0.9 (0.7–1.1) | 176 (13.7) | 1.1 (0.8–1.4) | 235 (18.3) | 1.1 (0.9–1.4) |
30–44 | 657 (18.4) | 1.1 (0.9–1.4) | 645 (18.1) | 1.4 (1.2–1.7) | 667 (18.7) | 1.1 (0.9–1.3) |
45–64 | 361 (15.0) | 0.9 (0.7–1.2) | 402 (16.7) | 1.3 (1.0–1.7) | 369 (15.3) | 0.8 (0.7–1.0) |
65+ | 143 (13.7) | 0.9 (0.7–1.2) | 157 (15.0) | 1.3 (0.9–1.7) | 152 (14.6) | 0.8 (0.6–1.1) |
Lifetime number of sexual partners | ||||||
1 (referent) | 537 (10.6) | — | 557 (11.0) | — | 646 (12.8) | — |
2–3 | 654 (20.3) | 2.1 (1.8–2.3) | 660 (20.5) | 2.0 (1.7–2.2) | 656 (20.4) | 1.7 (1.5–1.9) |
4+ | 318 (28.9) | 3.1 (2.6–3.7) | 297 (27.0) | 2.6 (2.2–3.1) | 300 (27.2) | 2.3 (2.0–2.8) |
Number of recent sexual partners | ||||||
0 | 297 (16.0) | — | 315 (17.0) | — | 305 (16.4) | — |
1 | 1153 (15.8) | 0.9 (0.8–1.1) | 1134 (15.6) | 0.9 (0.8–1.1) | 1235 (16.9) | 0.9 (0.8–1.1) |
2+ | 58 (26.9) | 0.9 (0.6–1.3) | 65 (30.1) | 1.3 (0.9–1.8) | 60 (27.8) | 1.0 (0.7–1.5) |
Age at first intercourse | ||||||
<16 (referent) | 415 (21.1) | — | 419 (21.4) | — | 403 (20.5) | — |
16–19 | 726 (15.7) | 0.8 (0.7–1.0) | 718 (15.5) | 0.8 (0.7–0.9) | 816 (17.6) | 1.0 (0.8–1.1) |
20+ | 367 (13.3) | 0.8 (0.7–1.0) | 376 (13.6) | 0.8 (0.6–0.9) | 382 (13.8) | 0.8 (0.7–1.0) |
Smoking | ||||||
Never (referent) | 1285 (15.5) | — | 1304 (15.7) | — | 1380 (16.6) | — |
Former | 111 (19.6) | 1.2 (0.9–1.4) | 105 (18.5) | 1.0 (0.8–1.3) | 114 (20.1) | 1.2 (0.9–1.5) |
Current | 113 (22.9) | 1.2 (1.0–1.5) | 103 (20.9) | 1.1 (0.8–1.3) | 107 (21.7) | 1.1 (0.9–1.4) |
Oral contraceptive use | ||||||
Never (referent) | 511 (13.9) | — | 553 (15.1) | — | 570 (15.5) | — |
Former | 671 (17.0) | 1.3 (1.1–1.5) | 683 (17.4) | 1.2 (1.0–1.4) | 708 (18.0) | 1.1 (1.0–1.3) |
Current | 326 (18.5) | 1.5 (1.2–1.8) | 277 (15.7) | 1.2 (1.0–1.4) | 324 (18.4) | 1.1 (0.9–1.3) |